Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome. (2022)
Attributed to:
Definition and induction of broadly protective responses against HIV-1
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.103956
PubMed Identifier: 35325780
Publication URI: http://europepmc.org/abstract/MED/35325780
Type: Journal Article/Review
Volume: 78
Parent Publication: EBioMedicine
ISSN: 2352-3964